AstraZeneca-Daiichi's breast cancer drug improves survival in study

(marketscreener.com) AstraZeneca said on Monday its cancer treatment, Enhertu, developed with Japan's Daiichi Sankyo delayed the progression of a form of advanced breast cancer in previously treated patients.https://www.marketscreener.com/quote/stock/DAIICHI-SANKYO-CO-LTD-6498062/news/AstraZeneca-Daiichi-s-breast-cancer-drug-improves-survival-in-study-41314013/?utm_medium=RSS&utm_content=20220815